January 24th 2011 | Patient Stories | 0 Comments
Too bizarre to make up?
Lead singer Liam Gallagher of Oasis — one of the great (if currently-disbanded) rock bands of our time — recently disclosed he has severe psoriasis as part of a strange anecdote recounted by the Sun tabloid in the UK:
“I’ve got psoriasis all over my [expletive deleted] body. Everywhere except for me
READ THE FULL POST
January 19th 2011 | Biologics, Psoriasis Research, Treatment | 0 Comments
Even treatments that are already approved by the U.S. Food and Drug Administration (FDA) are frequently tested further in clinical trials under close medical supervision. Such trials typically offer free meds and thorough medical screening – a great deal for patients. Check out our full report on psoriasis research studies for FDA-approved treatments.
With more
READ THE FULL POST
January 15th 2011 | Biologics, Psoriasis Research, Side-effects of treatment | 13 Comments
Abbott today announced in a securities filing that it has withdrawn its application with the U.S. Food and Drug Administration (FDA) and European regulators to market its much-anticipated, experimental psoriasis treatment briakinumab (ABT-874, Ozespa). The biologic, like Centocor Ortho Biotech’s Stelara (ustekinumab), targets two internal proteins linked to inflammation, IL-12 and IL-23. Briakinumab
READ THE FULL POST
